🔎 Trials Near Me

Home › Focal Segmental Glomerulosclerosis › North Carolina › Durham

Focal Segmental Glomerulosclerosis clinical trials in Durham, NC

8 studies for Focal Segmental Glomerulosclerosis are looking for participants at sites in and around Durham (within about 30 miles). Open a study to see who can join and how to contact the study team.

A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)

RecruitingPhase 3
  • Duke University Medical Center, Durham
Ages 12 and older · All sexes · Updated Sep 30, 2026 · NCT07220083

A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease

RecruitingPhase 2
  • UNC Kidney Center- Site Number : 8400021, Chapel Hill · 10 mi away
Ages 16 to 75 · All sexes · Updated Sep 23, 2026 · NCT06500702

Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children

Recruiting
  • University of North Carolina, Chapel Hill · 10 mi away
Up to age 21 · All sexes · Updated Aug 28, 2026 · NCT02235857

Post Approval Study for Treatment of Drug-resistant Adult and Pediatric Primary FSGS Using the LIPOSORBER® LA-15 System

Recruiting
  • University of North Carolina, Chapel Hill · 10 mi away
Up to age 75 · All sexes · Updated Aug 28, 2026 · NCT04065438

NEPTUNE Match Study

Recruiting
  • University of North Carolina Chapel Hill, Chapel Hill · 10 mi away
Ages 1 to 80 · All sexes · Updated Jun 10, 2026 · NCT04571658

Nephrotic Syndrome Study Network

RecruitingObservational study
  • University of North Carolina at Chapel Hill, Chapel Hill · 10 mi away
Up to age 80 · All sexes · Updated Jun 10, 2026 · NCT01209000

Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases

RecruitingPhase 2
  • Duke Molecular Physiology Institute, Durham
  • University of North Carolina at Chapel Hill, Chapel Hill · 10 mi away
Ages 1 to 17 · All sexes · Updated May 12, 2026 · NCT05003986

A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB

RecruitingPhase 3
  • University of North Carolina, Chapel Hill · 10 mi away
Ages 12 to 80 · All sexes · Updated Feb 3, 2026 · NCT05183646

Focal Segmental Glomerulosclerosis trials in other cities

Other studies in Durham

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.